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Abstract
The case is presented of a 52-year-old female patient who was diagnosed as having fungal
endocarditis due to the Mucor species infection. The patient had had permanent cardiac
pacing for 23 years. She was admitted to the hospital with symptoms of sepsis, and TTE
revealed the development of vegetations on the pacemaker leads. Cardiac surgery with removal
of the infected system was performed and a new pacemaker with an epicardial lead was
implanted. After the surgery the patient’s clinical course was complicated by multiple organ
dysfunction syndrome and septic shock, which was resistant to traditional treatment. Admin-
istration of human recombinant activated protein C (Xigris) improved organ function and
enabled selective antifungal therapy to be continued. The patient was discharged from hospital
48 days later in a good condition. (Folia Cardiol. 2006; 13: 344–347)
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Introduction
Mucormycosis is an infrequent acute fungal
infection, which has an extremely high mortality
rate even with aggressive surgical intervention.
The manifestations of such endocardiac and valve
mucormycosis have been reported in patients after
cardiac surgery [1, 2]. The major aetiological agents
of mucormycosis are common saprophytic mould
fungi (of the Mucorales type), frequently found in
the soil and decaying food and vegetables. The spo-
res of these fungi are ubiquitous and gain entrance
to the human body through the mouth and nose,
where they attach themselves to the nasal or oral
mucosa in the form of characteristic deeply furro-
wed cotton-like colonies. Spread occurs when the
fungus invades the nasal cavity, which may result
in rapid progressive pneumonia. The spores may
also enter the body through injured skin and/or
surgical wounds, directly invading blood vessels,
which can lead to inflammation, thrombosis, infrac-
tions and necrosis of the infected tissue. Infection
is described almost exclusively in patients with
compromised immune systems and in patients with
poorly controlled diabetes. The conditions most
commonly associated with this type of infection also
include chronic steroid use, antibiotic therapy and
treatment with cytostatics [3]. Thus far, to the au-
thor’s knowledge, there have been no reports de-
scribing fungal endocarditis caused by Mucor spe-
cies in the course of long-term cardiac pacing.
Case description
A 52-year-old female patient with cardiac pa-
cing programmed in VVI mode and implanted in
345
Wiesława Duszyńska et al., Fungal endocarditis complicated by shock
www.fc.viamedica.pl
1981 was admitted to the hospital because of sick
sinus syndrome and a third degree paroxysmal AV
block followed by loss of consciousness. In 1990,
9 years after the initial implantation, she was ad-
mitted to the Electrostimulation Department for the
first follow-up as a result of a sudden loss of con-
sciousness. The investigation revealed malfunction
of the pacemaker lead and the patient was readmit-
ted for implantation of a new pacemaker system.
Because of venous confluence malformation, access
to the same pocket of the heart was achieved thro-
ugh the right external jugular vein and the old lead
was removed. However, the patient did not comply
with the pacemaker follow-up protocol. In 2002 she
was admitted to the hospital following several epi-
sodes of fainting. The pacemaker battery was com-
pletely discharged, requiring immediate replace-
ment. Following these two surgical interventions
no complications were reported during the perio-
perative period. Two years later, in August 2004,
the patient was readmitted because of purulent dra-
inage from the surgical wound on the neck. She
reported that she had been unsuccessfully trying
different home methods to treat the wound. Under
the cefuroxim antibiotic cover the inflamed tissues
were removed, which resulted in a proper healing
of the wound. All cultures of the wound drainage
developed Staphylococcus epidermidis strains. Ac-
cording to well-accepted standards for active endo-
carditis, blood samples were collected and the mi-
crobiological cultures were performed in the uni-
versal growth medium BacT/ALERT. All the blood
cultures were negative, and the good clinical con-
dition of the patient did not suggest ongoing endo-
carditis at that time. The patient was discharged
from hospital on prescribed antibiotic treatment (for
two weeks), which included amoxycyclin with ca-
lvulinic acid. Six weeks later she developed fever,
hyperhidrosis, cough and a general progressive
weakness. After one week of in which she self-
-administered antipyretic drugs she was admitted
to another local hospital and was initially treated for
pneumonia. After a few days, diagnosed with endo-
carditis, she was admitted for continuing treatment
to the Department of Cardiac Surgery. The trans-
oesophageal echocardiography examination showed
enlargement of the left ventricle (ED = 68 mm,
ES = 50 mm) with decreased global ventricular
function, and the ejection fraction was 46.5% (ac-
cording to the Teicholtz formula). Furthermore, one
of the pacemaker leads in the atrium showed the
presence of a large spherical mass (24.5 × 21 mm),
indicating vegetations balling out into the ostium
of the tricuspid valve (Fig. 1). No vegetation was
noted on the slightly thickened cusps of either the
mitral or the tricuspid valves, which had signs of
mild regurgitation. Blood cultures were still nega-
tive. The patient, who was qualified for urgent sur-
gical intervention, was treated empirically with van-
comycin and cefuroxim. During surgery both endo-
cavitary leads were removed. There was one large
mass of vegetation (30 × 20 × 10 mm) and several
small ones attached to one of the leads. The old
pacemaker system was extracted and the new one
was implanted into the abdominal integument and
then connected with the epicardiac pacing lead.
Tricuspid valvuloplasty was also performed. Sam-
ples for microbiological tests (cardiac cavity blood,
cardiac and tricuspid valve tissue and pacing lead
tips) were collected during the surgery. Tissue sam-
ples and the lead tips were placed into sterile con-
tainers with Schaedler medium, used for the culti-
vation of fungi. Blood samples were collected in
BacT/ALERT medium and a wound swab, perfor-
med by using wooden applicators, was transferred
into the AMIES BO41 (AAGMED RAWA) vial with
transport medium. All samples were immediately
sent to the microbiological clinical laboratory. Al-
though antibiotic therapy was continued with the
adjunction of antifungal drug 5-fluorocytosin, the
fever still persisted. On the patient’s neck along the
right jugular vein a swelling and redness of the area
where the old lead had been placed were observed
as well as an increase in skin surface temperature
and significant swelling of the right arm. Four days
later the patient’s clinical course deteriorated as
a result of circulatory and respiratory insufficiency,
and she was transferred for further treatment to the
Department of Anaesthesiology and Intensive
Therapy. Despite intensive supportive care her
Figure 1. Two-dimensional echocardiograph showing
massive vegetations on the pacing lead in the right atrium.
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clinical course was complicated by septic shock with
multiple organ dysfunction syndrome. The patient
was intubated and an optimal treatment according
to standard procedures was initiated [4]. The 7-day
microbiological cultures of the intraoperative sam-
ples developed an exclusive fungus. On the basis
of the macroscopic and microscopic findings the
fungus was identified as Mucor species.
Previous antibiotic therapy was stopped and
meronem with amphotericin B was administered.
In view of the patient’s continued deterioration and
lack of reaction to the antimicrobial therapy, human
recombinant activated protein C (Xigris, Eli Lilly)
was added (96-hour infusion) on the third day of
septic shock, which resulted in gradual stabilisation
of the circulatory system and significantly impro-
ved liver and kidney function parameters on the
second day of treatment. The patient was extuba-
ted 15 days after surgery and non-invasive ventila-
tion was then conducted through a nose mask.
A control TTE examination indicated that left ventric-
le enlargement (ED = 62 mm, ES = 43 mm) and ejec-
tion fraction were improved (EF = 52%). No vegeta-
tions were detected and all blood samples were ne-
gative. In addition, both the pulmonary changes and
the local skin infections of the neck healed rapidly,
and on day 28 the patient started her own respiration.
At this point she was given oral drugs including kar-
wedilol, digoksin, furosemid, and trandolarpil. After
48 days of hospitalisation the patient was discharged
in a good condition, cardiological medications having
been prescribed. At present (June 2005) the patient
has shown showed no recurrence of infection recur-
rence during 6 months follow-up, and her clinical con-
dition is good. However, recent TTE examinations
have identified enlargement of the left ventricle
(ED = 63 mm, ES = 43 mm) with an ejection fraction
EF = 55% and slight thickening of both the mitral and
tricuspid valves without any signs of vegetation. Ad-
ditional follow-up examinations have revealed no car-
diac insufficiency.
Discussion
Infective endocarditis is a rare complication of
permanent cardiac pacing. The incidence of infec-
tion following pacemaker implantation ranges from
1% to 7% and is caused mostly by staphylococci [5–8].
Fungal endocarditis is very infrequent and thus far
only a few clinical cases have been described. Most
commonly it is caused by Candida albicans, Asper-
gillus fumigatus, and Acremonium species [9–12].
Fungal endocarditis is particularly common follo-
wing repeated surgeries involving pacemaker sys-
tem replacements or in association with infections
of surgery wounds, bedsores, and fistulae in the
pacemaker area, as well as prolonged antibiotic the-
rapy. Mortality rate in the course of fungal endo-
carditis is high (40–70%) and in patients undergo-
ing conservative therapy may even reach 100%
[5, 8, 13]. The diagnosis is often delayed because of
negative test cultures at the early stages and the fact
that admission to the hospital usually takes place at
an advanced stage of the disease. According to pu-
blished reports, transthoracic and, particularly, trans-
oesophageal echocardiography seem to be very use-
ful for early diagnosis of endocarditis [9, 10, 13]. This
should be performed in all patients with prolonged
fever who have implanted cardiac electrotherapy
devices (defibrillators and pacemakers). Common
features of fungal endocarditis, often observed intra-
operatively, are large vegetations with extensive
infiltrations and focal lesions in the cardiac muscle.
Early diagnosis of mucormycosis endocarditis
is very difficult and is usually proven at autopsy.
Mycological tests are time consuming and are usu-
ally performed by means of direct microscopic eva-
luation or culture of different samples, including se-
cretions, tissues and blood. In all the cultures stu-
died a compact mass of threadlike irregular
filaments can be observed, forming the mycelium
of a fungus.
Spores of Mucor species can be inhaled through
the mouth and nose, or they may enter the body
through injured skin, directly invading the blood
vessels, which can lead to inflammation and syste-
mic infection (sepsis) or its severe form — septic
shock. Despite advances in diagnosis, treatment of
mucormycosis endocarditis is very difficult. The use
of prolonged amphotericin therapy combined with
surgery (extraction of the source of infection) re-
mains the mainstay of treatment. Amphotericin is
a high efficiency antifungal drug but has many se-
rious side effects. It is important to continue using
this medicine for at least two weeks and, if it is well
tolerated, even up to 6–8 weeks.
In the reported case it was not possible to es-
tablish definitely the exact time and entry of the
fungal infection. Although inoculation of the fungus
could take place through the surgical wound after
the previous surgical replacement of the cardiac
pacemaker (in 2002), such a long period from the
onset of infection to the first symptoms of the dise-
ase seems unlikely. It is quite possible that our
patient developed a respiratory tract infection cau-
sed by spores inhaled from the air which subsequ-
ently penetrated to the blood vessels. Another
possibility could be a neck wound infection at the
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site of the damaged skin above the pacemaker lead
and an expansion of the inflammatory process to the
heart. The last mechanism seems to be the most
likely. This was a patient at high-risk of infective
endocarditis because of several factors, including
surgical interventions, the presence of two pacema-
ker leads in the heart (one of which was 23 years
old) and patient non-compliance with follow-up re-
gimens. All the procedures in this case were the-
refore performed urgently because of the life thre-
atening condition of the patient (disruption of lead
continuity, complete discharge of the pacemaker
battery, using home methods to heal the neck wo-
und and high fever upon hospital admission). The
Mucor species fungus, which is resistant to standard
chemotherapeutics and which was a major aetiolo-
gical factor, was detected in test cultures 7 days
after surgery. By this time the patient had develo-
ped all the symptoms of septic shock. However, she
survived because of the successful therapeutic
management of septic shock and multiple organ
dysfunction, performed at the Department of Ana-
esthesiology and Intensive Therapy. Another criti-
cal factor was the administration of human recom-
binant activated protein C, which significantly re-
duces mortality in patients with severe sepsis and
organ failure [4]. According to recent reports, this
drug is an effective anticoagulant and has anti-in-
flammatory, anti-apoptotic, and profibrinolytic pro-
perties. In the reported case this drug blocked the
development of circulatory-respiratory dysfunction,
which resulted in more effective antibiotic activi-
ty. The septic shock treatment with activated pro-
tein C may be associated with the non-specific ac-
tion of this drug. This mechanism may be respon-
sible for inhibiting the pathomechanism of sepsis,
not by directly influencing pathogenic micro-orga-
nisms, but rather by breaking the vicious circle of
the self-driving pathological processes such as in-
flammation and intravascular clotting.
This is a new and extremely promising direc-
tion for the effective therapy of difficult systemic
infections and septic shock. However, administra-
tion of human recombinant protein C should take
place only under very strictly controlled conditions
and according to well-established indications and
contraindications associated with the monitoring of
the clinical course [4]. This drug may, therefore,
only be applied in intensive care units.
Conclusions
1. Fever of unknown aetiology in patients with
implanted cardiac electrotherapy systems sho-
uld always carry a clinical suspicion of infecti-
ve endocarditis.
2. Fungi may be considered an aetiological factor
of infective endocarditis.
3. Echocardiography evaluation is a valuable dia-
gnostic procedure in patients clinically suspec-
ted of infective endocarditis.
4. The only effective management of patients with
infective endocarditis and vegetations detected
on pacemaker leads requires urgent removal of
the entire pacing system and administration of
empirical followed by direct antibiotic therapy.
5. Administration of human recombinant activated
protein C significantly reduces multiple organ
dysfunction during the course of septic shock and
enables further effective therapy to be performed.
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